Evidence map›Paper›PMID 22790866›Full record

ArticleClinical & experimental metastasis2013

Development of a tridimensional microvascularized human skin substitute to study melanoma biology.

Laure Gibot, Todd Galbraith, Jacques Huot, François A Auger

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & experimental metastasis, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 51 citations in OpenAlex.

  1. Isolation and Culture of Human Dermal Microvascular Endothelial Cells.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  2. In Vitro and In Silico Evaluation ofPlants (Basel, Switzerland) · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Tissue Engineering for Gastrointestinal and Genitourinary Tracts.International journal of molecular sciences · 2022
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Modeling human bladder cancer.World journal of urology · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Proteoglycans in Normal and Healing Skin.Advances in wound care · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Laure GibotLOEX, Centre de recherche FRSQ du CHA de Québec, Quebec City, QC, Canada.
Todd Galbraith
Jacques Huot
François A Auger
Université Laval · CA

Funding

Canadian Institutes of Health Research SAC-92850
6 · The paper itself

Abstract

Cutaneous malignant melanomas represent an important clinical problem because they are highly invasive, they can metastasize to distant sites and are typically resistant to available therapy. The precise molecular determinants responsible for melanoma progression and chemo-resistance are not yet known, in part due to lack of pertinent experimental models that mimic human melanoma progression. Accordingly, we developed a complex human microvascularized reconstructed skin substitute in which the organized three-dimensional (3D) architecture of the native skin is reproduced. Human melanoma cell lines derived from primary and metastatic sites were added to this 3D model. Our results demonstrate that histological features and behavior of melanoma cells applied in our skin substitute model are specific to their site of origin. In particular, the ability of melanoma cells to cross the dermal-epidermal junction correlates with their metastatic potential. In addition, a potent angiogenic effect was detected for an aggressive metastatic cell line that produces VEGF. The presence of a microvascular network within this model will allow studying a crucial step of the metastatic process. We conclude that such an in vitro human tumor microvascularized reconstructed skin substitute promises to be a versatile and efficient model to investigate skin cancer progression and to screen new anticancer drugs to improve currents clinical treatments.

Indexed as

ApoptosisNecrosisSkin, ArtificialCells, CulturedDermisEndothelium, VascularEnzyme-Linked Immunosorbent AssayHumansImmunoenzyme TechniquesMelanomaSkin Neoplasms

Identifiers

PMID22790866
OpenAlexW2012377264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.